TET2 and pulmonary arterial hypertension: Our previously reported haemodynamic data for these patients confirm that PAH driven by a mutation in the TET2 gene is no more severe than in those without the mutation; indeed, PVR was higher in those without the TET2 mutation (Potus et al. 2020).